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Introduction
Modification of proteins with ubiquitin (Ub) is involved in 
almost all fundamental cellular functions, including regulation 
of the cell cycle, DNA repair, apoptosis, gene expression, and 
signal transduction (Hershko and Ciechanover, 1998; Fang and 
Weissman, 2004). In addition, ubiquitination plays a central 
role in the homeostasis and quality control of proteins expressed 
by the secretory pathway. The latter function of Ub is largely 
performed by ER-associated degradation (ERAD), which tar-
gets aberrant proteins for proteasome-dependent degradation 
(Hampton, 2002; Kostova and Wolf, 2003; Meusser et al., 2005; 
Sayeed and Ng, 2005). Not surprisingly, abnormalities in the 
ubiquitination system cause numerous human diseases ranging 
from  neurodegenerative  diseases  to  cancers  (Glickman  and 
Ciechanover, 2002). Using an evolutionarily conserved mecha-
nism, ubiquitination is performed by a cascade of three types of 
enzymes: activating enzyme E1, conjugating enzyme E2, and 
ligase E3. Ub is first activated by E1, which forms a thiolester 
with the C-terminal Gly of Ub in an ATP-dependent manner. 
The activated Ub is then transiently transferred to a conserved 
cysteine (C) residue of an E2. Finally, the charged E2 interacts 
with an E3 and facilitates the transfer of the Ub moiety to lysine 
(K) residues of the substrate or less commonly to the -amino 
group of the N-terminal amino acid of a substrate (Ciechanover 
and Ben-Saadon, 2004). The interaction of E2–E3 is also re-
sponsible  for  the  assembly  of  poly-Ub  chains  on  substrates 
(Pickart, 2001). All seven K residues of Ub have been found to 
participate in the formation of poly-Ub chains in vivo. However, 
the most abundant chains detected by mass spectrometry analy-
ses of modified yeast proteins are linked through K48, K63, and 
K11 residues (Peng et al., 2003; Xu et al., 2009). K48-linked 
poly-Ub chains typically target the substrate for proteasomal 
degradation in the cytosol, whereas K63-linked poly-Ub chains 
are usually involved in endocytosis, DNA repair, and signal 
transduction (Pickart and Fushman, 2004; Chen and Sun, 2009). 
More  recently  K11-linked  chains  were  also  found  to  target 
ERAD substrates for proteasome degradation (Jin et al., 2008; 
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Ube2j2 have been implicated in ERAD (Kostova et al., 2007). 
In addition, cytosolic E2s such as Ube2k (also called E2-25k; 
homologue of yeast Ubc1p) and Ube2d1 (homologue of yeast 
Ubc5a) were reported to be involved in ERAD in mammals 
(Younger et al., 2004; Flierman et al., 2006). In higher eukary-
otes, including mammals, there is also a growing list of ER 
membrane–associated E3 ligases (Fang et al., 2001; Didier et al., 
2003; Nadav et al., 2003; Kikkert et al., 2004; Hassink et al., 2005; 
Kreft et al., 2006; Brauweiler et al., 2007; Lerner et al., 2007). 
However,  with  the  exception  of  the  recently  characterized 
Ube2g2–gp78 complex (Li et al., 2007, 2009; Das et al., 2009), 
the functional interaction of these E2s with their cognate E3s 
has not been well characterized. Genetic studies of yeast sug-
gested that Ubc6p interacts with ligase Doa10 to induce ubiqui-
tination and proteasome degradation of model ERAD substrates 
(Swanson et al., 2001; Ravid et al., 2006). Interestingly, Doa10 
is a RING-CH–type ER membrane–bound E3 ligase similar to 
mK3. However, in mammals, no cognate E3 ligases of Ube2j2 
(Ubc6p homologue) have been identified.
In this study, permeabilized cells were used to show that 
Ub-conjugating enzymes Ube2j2 and Ube2d1 can interact with 
mK3 to promote the ubiquitination of HC substrates, whereas 
other  potential  ERAD-associated  E2s  cannot  interact  with 
mK3. Using permeabilized cells expressing mK3 and HC mu-
tants having only 1K or 1S Ub acceptor site, Ube2d1 only 
ubiquitinated K residues on HC substrates, whereas Ube2j2 
could ubiquitinate either S or K residues. Interestingly, using 
wild-type (WT) HC substrates, inhibition by short hairpin RNA 
(shRNA) of only Ube2j2 resulted in impaired ubiquitination 
and induced stabilization of HCs, demonstrating that Ube2j2 is 
the primary E2 interacting with mK3 ligase in vivo. Further-
more, the Ub conjugates on the WT HC mediated by Ube2j2–
mK3 were sensitive to mild alkaline treatment, indicating that 
this E2–E3 interaction strongly favors the ubiquitination of 
hydroxylated residues on HC substrates even in the presence 
of K residues. Importantly, the preferential ubiquitination of   
hydroxylated residues of HC by Ube2j2–mK3 was not the re-
sult of differential deubiquitination by C proteases. Thus, these 
findings demonstrate for the first time that the same E2–E3 
complex can catalyze the coupling of Ub to substrates via   
either an isopeptide bond or an ester bond and that this latter 
form of nonconventional ubiquitination can be preferentially 
used to induce ERAD.
Results
Membrane-bound E2s support the 
ubiquitination of the HC by mK3 ligase
To test whether the cellular E2 supporting mK3 ubiquitination 
of HC is membrane associated, a permeabilized cell system was 
used (Shamu et al., 1999). WT3 cells expressing mK3 ligase 
and its substrate L
d HCs were treated briefly with digitonin and 
then centrifuged to separate cytosolic proteins in solution from 
membrane proteins in the pellet. Next, pellets of permeabilized 
cells  were  resuspended  with  an  energy-regenerating  system 
(Feldman et al., 1997) and buffer containing E1, E1 + HA-Ub, 
or fraction II (FII; which contains E1, most E2s, some E3s, and 
Xu et al., 2009). Despite the fact that subtle differences in the 
ubiquitination of substrates dictate their fate, the mechanisms 
governing substrate residue selection and Ub chain assembly 
remain poorly understood. A major hindrance for addressing 
this critical issue in mammals is the lack of defined E2–E3 
interactions for physiological substrates.
Surprisingly, recent discoveries indicated that Ub moi-
eties can be linked to substrates by thiolester or ester bonds. 
These two types of conjugations were found to be mediated by 
related viral E3 ligases that share a highly homologous RING 
(really interesting new gene)-CH domain, transmembrane to-
pology, and the ability to target major histocompatibility com-
plex class I heavy chains (HCs) as an immune evasion strategy. 
The  kK3  and  kK5  ligases  of  Kaposi’s  sarcoma-associated   
herpesvirus (KSHV) promote ubiquitination of C or K residues 
on HC substrates, resulting in their rapid endocytosis and deg-
radation in the lysosome (Cadwell and Coscoy, 2005, 2008). In 
contrast, the murine K3 (mK3) ligase of murine -HV68 pro-
motes the ubiquitination of hydroxylated amino acids (serine 
[S] or threonine [T]) or K residues on HCs, resulting in their 
ERAD (Wang et al., 2007; Herr et al., 2009). Whether the same 
E2s  or  specialized  E2s  are  responsible  for  interacting  with 
kK3/kK5 or mK3 to form thiolester or ester versus isopeptide 
linkages has not been reported. Thus, questions remain about 
the molecular mechanisms of these novel forms of non-K ubiq-
uitination. However, there is increasing indirect evidence for 
the physiological relevance of substrate ubiquitination via thio-
lester or ester bonds. For example, an extensive mutagenesis 
study by Tait et al. (2007) showed that apoptosis induction by 
Bid requires the ubiquitination of S and C residues on its   
N-terminal fragment. Furthermore, in yeast and mammals, it was 
revealed that export of Pex5p, a peroxisomal import recep-
tor, requires ubiquitination of a conserved C residue of Pex5p 
(Carvalho et al., 2007; Williams et al., 2007). Thus, non-K 
ubiquitination appears to be a conserved mechanism in yeast 
and mammals, suggesting that it is a physiologically important 
posttranslational modification.
In yeast, there are three E2s, Ubc6p, Ubc7p, and Ubc1p, 
that are known to be involved in the ERAD of misfolded/ 
unassembled lumenal or ER membrane proteins (Chen et al., 
1993; Sommer and Jentsch, 1993; Hiller et al., 1996; Biederer 
et al., 1997; Friedlander et al., 2000; Bays et al., 2001). Both 
Ubc6p and Ubc7p are ER membrane associated. Interestingly, the 
ERAD of different substrates mediated by the E3 ligase Hrd1/
Der3 requires predominantly Ubc7p or, less frequently, Ubc1p 
(Bays et al., 2001). However, ERAD mediated by the E3 ligase 
Doa10 depends exclusively on Ubc6p and Ubc7p (Swanson 
et al., 2001; Ravid et al., 2006), suggesting that these E2s may 
preferentially interact with E3 ligases to induce the ERAD of a 
different subset of substrates (Kikkert et al., 2005; Kostova et al., 
2007). In mammals, there are two clear homologues of yeast 
Ubc6p and Ubc7p named Ube2j2 and Ube2g2, respectively 
(Tiwari and Weissman, 2001). In addition, homologues with less 
sequence identity to yeast Ubc6p and Ubc7p have been identi-
fied in mammals and named Ube2j1 (also called Ubc6e) and 
Ube2g1 (Lester et al., 2000; Lenk et al., 2002; Kostova et al., 
2007). Of the four of these homologues, Ube2g2, Ube2j1, and 657 Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
the hypothesis that a cognate E2 of mK3 is membrane bound. 
Consistent with this conclusion, samples with added FII frac-
tion (likely containing most soluble E2s) gave less robust ubiq-
uitination of HC (lanes 11 and 12). Furthermore, by using the 
cells expressing a catalytically inactive RING mutant of mK3, 
we confirmed that ubiquitination in the permeabilized system 
was indeed mediated by mK3 (Fig. S1). Collectively, these data 
validate the approach and further suggest that a membrane-
bound E2 can support mK3-mediated ubiquitination of HC.
Ube2j2 supports both ester- and amide-
linked ubiquitination of the HC by mK3
We next wanted to determine whether the cognate E2s of mK3 
are the same or different for ubiquitination of hydroxylated 
versus K residues. For this purpose, an L
d HC mutant with one 
S in its native position 329 (L
d 1S) was made on a template 
lacking C, K, S, and T residues on the tail (L
d ∆CKST; Fig. 2 A). 
To exclude possible position effects, a similar L
d mutant was 
also made by replacing L
d 329S with a K residue (L
d 1K). 
Cells expressing either the 1S or 1K HC mutants and mK3 
were permeabilized, and the membrane portions were incu-
bated with E1 and E2 in the presence of ATP and HA-Ub. All 
known ER membrane–associated E2s and their homologues in 
the mouse (Ube2g1, Ube2g2, Ube2j1, and Ube2j2) and two 
mouse cytosolic E2s, Ube2k and Ube2d1, implicated in ERAD 
were tested. Ube2n was also included as a negative control. 
Each of these seven E2s was expressed as a soluble recombi-
nant protein in Escherichia coli and normalized for enzymatic 
the proteasome) + HA-Ub. After incubation, the reaction mix-
ture was separated into the supernatant and pellet fractions. 
Samples from the supernatant and pellet fractions of these three 
experimental groups as well as samples from the cytosolic pro-
tein fraction were tested by immunoblot to verify the elimina-
tion of cytosolic proteins (Ube2n and Ube2k) and the retention 
of membrane proteins such as mK3 (Fig. 1 A). The de novo Ub 
conjugates on the HCs in these supernatant and pellet fractions 
were identified by immunoprecipitation of the HC and blotting 
for HA. To clearly distinguish the ubiquitinated HC from non-
specific bands, half of the HC precipitates were treated with 
endoglycosidase H (Endo H). This treatment cleaves the high 
mannose glycan moieties from immature HCs (nonubiqui-
tinated as well as ubiquitinated), resulting in a down shift of 
corresponding HC bands in the gel. From the experiment shown 
in Fig. 1 B, four important conclusions can be drawn. First, 
Endo H–sensitive ubiquitinated HC bands were only observed 
in the samples incubated with HA-tagged Ub (lanes 7, 8, 11, 
and 12) but not in the samples without added HA-Ub (lanes 
1–4). Thus, only newly ubiquitinated HCs were detected in the 
HA blots. Second, the pattern of the de novo ubiquitinated HCs 
in the permeabilized cells is the same as previously seen with 
nonpermeabilized cells (Wang et al., 2007), demonstrating re-
capitulation of what is observed in vivo. Third, the ubiquitinated 
HCs were only detected in the pellet, indicating that they were 
membrane bound, which is consistent with in vivo observations 
(Wang et al., 2007). Fourth, profound ubiquitination of HC was 
detected in the samples with only E1 (lanes 7 and 8), supporting 
Figure 1.  Membrane-bound E2s support the ubiquitination of the HC by mK3. (A) Mouse WT3 cells coexpressing WT L
d and mK3 were treated briefly 
with digitonin. The cytosolic proteins (CP) in solution and membrane proteins in the pellet were separated by centrifugation. The pellet was then suspended 
with reaction buffer containing an ATP­regenerating system. Three aliquots were made from this suspension and incubated with E1 only, E1 + HA­Ub 
(Ub*), or rabbit reticulocyte FII + Ub*, respectively, and followed by centrifugation. Samples from supernatant (S) and pellet (P) of each group as well as 
the cytosolic protein fraction were blotted by the antibodies indicated to verify the depletion of the cytosolic proteins and the maintenance of membrane 
proteins in the pellet. It should be noted that FII likely contains most soluble E2s; thus, the supernatant fraction with FII added is Ube2k and Ube2n positive. 
(B) Precipitations of L
d HCs from the supernatant or the pellet fractions of three reaction groups described in A were performed using anti­L
d mAbs. The   
precipitates were blotted for newly formed Ub­L
d conjugates with anti­HA. An anti­L
d blot was included to show similar input in each group and as an   
Endo H treatment control. Data shown are representative of three independent experiments. (A and B) Molecular mass is indicated in kilodaltons. IB, immunoblot; 
IP, immunoprecipitation.JCB • VOLUME 187 • NUMBER 5 • 2009   658
Figure 2.  Ube2j2 interacts with mK3 to promote the Ub conjugation of S or K residues, whereas Ube2d1 interacts with mK3 to promote only ubiquitination 
of K residues. (A) Nomenclature and sequence alignment of the cytoplasmic tails of L
d mutants are shown with original WT residues in bold. (B) WT3 cells 
coexpressing L
d 329K (1K) and mK3 were permeabilized, cytosol depleted, and incubated with E1 and selective mouse E2 in the presence of ATP and 
HA­Ub. Precipitated L
d molecules (/+ Endo H) were resolved by SDS­PAGE and blotted for newly ubiquitinated L
d by anti­HA. An anti­L
d blot was included 
to show similar input in each group and as an Endo H treatment control. (C) After permeabilization and centrifugation, cells used in B were incubated with 
one of the four ER­associated E2s or homologues. Precipitates of L
d HCs were blotted for HA­Ub and L
d. (D and E) The same experiments were conducted 
as in B and C, respectively, using cells stably expressing L
d 329S (1S) and mK3. (B–E) Data are representative of at least two independent experiments. 
Molecular mass is indicated in kilodaltons. IB, immunoblot; IP, immunoprecipitation.659 Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
that Ube2j2 is the primary E2 that is required for mK3-induced 
initial Ub conjugation and chain assembly on S residues of 
HC substrates.
mK3 mediates dominant S/T  
ubiquitination on the tail of L
d while  
K residues are available
To determine whether mK3–Ube2j2 preferentially promotes 
the formation of ester bonds, we monitored the sensitivity of 
ubiquitinated HCs to mild alkaline treatment (Hershko et al., 
1980). WT3 cells expressing mK3 and L
d (WT, 1S, or 1K mu-
tants or ∆CKST as shown in Fig. 2 A) were permeabilized and 
incubated with reaction buffer containing ATP, E1, and Ube2j2. 
L
d HCs were then precipitated and treated with 0.1 M NaOH. 
As shown in Fig. 4 A, L
d ∆CKST molecules were not ubiqui-
tinated by Ube2j2 in the presence of mK3, confirming that the 
tail is indeed the site of ubiquitination. Furthermore, Ub con-
jugated by Ube2j2 on L
d 1S tails and not L
d 1K tails was found 
to be labile in 0.1 M NaOH, which is consistent with their re-
spective ester versus isopeptide bonds. Thus, these findings 
provided additional evidence that Ube2j2 has the capacity to 
cooperate with the mK3 ligase to form ester or isopeptide 
bonds  on  the  tails  of  HC  substrates.  Strikingly,  the  newly 
formed Ub conjugates on WT L
d molecules (as detected in HA 
blots) were also sensitive to the mild alkaline treatment, sug-
gesting that mK3–Ube2j2 preferentially ubiquitinates S resi-
dues on WT HC tails even though K residues are available. To 
extend these observations to nonpermeabilized cells, L
d HCs 
were precipitated from the lysates of the same intact cell lines, 
NaOH treated and blotted for Ub-HCs. Again, the Ub conju-
gates formed on WT L
d and L
d 1S were labile in mild alkaline 
conditions (Fig. 4 B). Collectively, these findings demonstrate 
that mK3 primarily interacts with Ube2j2 in vivo to preferen-
tially ubiquitinate hydroxylated amino acids on WT HC even 
when K residues are available.
Contribution of deubiquitinating  
enzymes (DUBs) to mK3-mediated  
Ub conjugation of HC
DUBs could potentially contribute to the dominant ubiquitina-
tion of hydroxylated amino acids on the WT HCs by mK3 if 
they preferentially cleave K-linked Ub conjugates rather than 
S/T-linked Ub conjugates. To test this possibility, a similar experi-
ment as in Fig. 4 A was conducted in the presence or absence 
of Ub aldehyde (Ub-Al), a potent inhibitor for all C protease 
families of DUBs (Pickart and Rose, 1986; Hershko and Rose, 
1987). It should be noted that a few known DUBs belong to the 
metalloprotease family and thus are not inhibited by Ub-Al, al-
though the majority of DUBs discovered so far are C proteases 
(Amerik and Hochstrasser, 2004). The results show that both 
S- and K-linked ubiquitination on either 1S or 1K L
d molecules 
conjugated by Ube2j2 and mK3 in a permeabilized cell system 
were enhanced by the inhibition of DUB activity with Ub-Al 
(Fig. 5 A), suggesting that the DUBs retained in permeabilized 
cells cleave both K Ub and S Ub conjugates. Although the ex-
tent of enhancement of ubiquitination after DUB inhibition was 
greater on 1K than 1S mutant HC substrates, the signal of 1S 
activity (Fig. S2, A and B). Of the seven E2s tested, Ube2d1 
and Ube2j2 were found to greatly enhance the Ub conjugation 
of  L
d  1K  (Fig.  2,  B  and  C).  Surprisingly,  Ube2j2  but  not 
Ube2d1 greatly enhanced the ubiquitination on L
d 1S mole-
cules (Fig. 2, D and E). In contrast, the other four E2s did not 
appreciably change the extent of ubiquitination of the HCs in 
comparison  with  samples  with  Ube2n  or  samples  without 
added E2 (E1 only). Thus, Ube2j2 can cooperate with mK3 to 
promote ubiquitination of either S or K residues on HC sub-
strates, whereas Ube2d1 can only support the ubiquitination 
on K and not S residues on HC substrates.
Ube2j2 is required for ubiquitination and 
ERAD of HC substrates by the mK3 ligase
To determine whether Ube2j2 and/or Ube2d1 is required for 
mK3-mediated  HC  ubiquitination  and  degradation,  shRNAs 
targeting specific E2s were introduced into WT3-L
d-mK3 cells 
individually. Target gene expression was evaluated by quantita-
tive RT-PCR (Fig. S3). shRNAs that yielded >70% inhibition 
were selected for comparisons (Table S1). Compared with con-
trols, the extent of ubiquitination of WT L
d in cells expressing 
Ube2j2 shRNA (S#1) was lower, especially in the HC bands 
containing more than two Ub moieties (Fig. 3 A, left). The spec-
ificity of this effect was confirmed by another Ube2j2 shRNA 
(S#2) that targets a different sequence on Ube2j2 (Fig. 3 B, 
left). In contrast to Ube2j2, inhibiting Ube2g1, Ube2g2, Ube2j1, 
Ube2k, and Ube2n had no effect on the levels of L
d ubiquitina-
tion (Fig. 3, A [left] and B [left]; and not depicted), although 
comparable levels of mK3 were expressed in each cell line 
(Fig. 3, A [middle] and B [middle]). Concordant with the reduced 
level of ubiquitination, the half-life of the L
d molecules was 
dramatically increased in cells with depleted levels of Ube2j2 
(Fig. 3, A [right] and B [right]). Thus, selective inhibition of 
Ube2j2 by shRNA resulted in impaired Ub conjugation and 
degradation of the HC substrates by mK3. In contrast, suppression 
of Ube2d1 by shRNA had no obvious effect on ubiquitination 
and stability of HCs (Fig. 3 A). Also, there was no additive 
effect observed when Ube2d1 shRNA was coexpressed with 
Ube2j2 shRNA (unpublished data). Thus, Ube2j2 is the uniquely 
required E2 supporting mK3 function in vivo.
As noted in the previous paragraph, inhibition of Ube2j2 
impaired polyubiquitination of HC substrates, yet Ub2-L
d forms 
were still detected. This finding suggests that either another E2 
besides Ube2j2 added the initial Ub moieties to HC substrates 
or that the residual levels of Ube2j2 after inhibition were suffi-
cient for initial ubiquitination but not chain assembly. To deter-
mine whether Ube2j2 is the primary E2 responsible for initial 
ubiquitination  as  well  as  chain  assembly  on  HC  substrates, 
WT3-L
d-mK3 cells expressing shRNA to Ube2j2 or Ube2d1 
were permeabilized. The membrane fraction of these cells was 
then incubated with ATP, HA-Ub, and E1. The ubiquitination of 
L
d HCs, including Ub1-L
d and Ub2-L
d, was severely impaired 
when Ube2j2 but not Ube2d1 was inhibited (Fig. 3 C), and this 
impaired ubiquitination was completely reversed by adding re-
combinant Ube2j2 to the reaction (Fig. 3 C). Furthermore, the 
same result was observed with cells expressing the 1S L
d mutant 
and mK3 (Fig. 3 D). Thus, these data definitively demonstrate JCB • VOLUME 187 • NUMBER 5 • 2009   660
Figure 3.  Ube2j2 is required for mK3-induced HC ubiquitination and degradation. (A) WT3 cells expressing WT L
d and mK3 were transduced by lentivirus­
based shRNA targeting one of the following Ub­conjugating enzymes: Ube2d1, Ube2g1, Ube2g2, Ube2j1, or Ube2j2 (S#1). After incubation with 50 µM 
MG132 for 2 h, L
d HCs were precipitated from these cells and followed by SDS­PAGE and blotting with anti­Ub and anti­L
d antibodies. The ­actin and 
mK3 blots in the middle panel were included to show a similar amount of input lysate and mK3 in each cell line. In the right panel, selected cell lines from 
the left panel were incubated for 24 h with 125 U/ml IFN­, pulse labeled with [
35S]Cys/Met, and chased for the indicated times with unlabeled Cys/Met. 661 Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
catalyzed by Ube2j2 with Ube2d1. In the presence of Ub-Al, 
in contrast to Ube2j2–mK3-catalyzed Ub-L
d conjugates, which 
were sensitive to NaOH treatment, Ub-L
d molecules conjugated 
by Ube2d1–mK3 were stable under the same conditions (Fig.   
5 C, lane 3 vs. lane 4), thus clearly demonstrating that these 
two E2s interact with mK3 to ubiquitinate different residues on   
the WT HCs. These findings show that Ube2j2 is directly re-
sponsible for the preferential ubiquitination of S/T residues on 
WT HC substrates. In addition, it is worthy to note that S/T   
Ub conjugates, once formed, may be more resistant to DUB-
mediated cleavage than K Ub conjugates. This is indicated by 
the greater enhancement of K Ub conjugates than S Ub conju-
gates upon DUB inhibition (Fig. 5 A, compare lane 2 vs. lane 1 
with lane 4 vs. lane 3). Preferential ubiquitination of S/T resi-
dues on WT HCs may be a strategy developed by -HV68 to 
effectively down-regulate major histocompatibility complex I 
molecules, thus evading CD8 cell detection.
ubiquitination was consistently stronger than that of 1K mol-
ecules regardless of whether DUB inhibitor was present or not 
(Fig. 5 A, lane 3 vs. lane 1 or lane 4 vs. lane 2). This finding 
further suggests that Ube2j2–mK3 favors the ubiquitination of 
S/T residues on HCs. Importantly, this preference can neither be 
attributed to the position of acceptor residue because the same 
position was used for 1K and 1S mutants nor by differential sus-
ceptibility of hydroxylated versus amide-linked Ub conjugates 
to DUB activity. It is also notable that there was a marked accu-
mulation of Ub conjugates on WT L
d molecules in the presence 
of Ub-Al (Fig. 5 B, lane 2 vs. lane 1), and these conjugates re-
mained sensitive to NaOH treatment (Fig. 5 B, lane 6 vs. lane 2).   
This observation demonstrates that dominant S/T-linked ubiq-
uitination on WT L
d molecules is not the consequence of dif-
ferential DUB activity but rather preferential S/T ubiquitination 
by Ube2j2–mK3. This conclusion is further supported by direct 
comparison of alkaline sensitivity of ubiquitinated WT HCs 
L
d precipitates were resolved by SDS­PAGE and visualized by autoradiography. Relative band intensities from the gels are plotted as a percentage of the 
intensity at time 0 for each cell line. Data are representative of three independent experiments. (B) WT3 cells expressing WT L
d and mK3 were transduced 
by retrovirus­based shRNA targeting Ube2j2 (S#2) or Ube2n or by an empty vector. The ubiquitination and degradation of L
d HCs were determined by   
immunoblotting and pulse–chase experiments as in A. Data are representative of three independent experiments. (C) Selected cells used in A and B were per­
meabilized, cytosol depleted, and incubated with E1 or E1 + Ube2j2 in the presence of ATP, HA­Ub, and Ub­Al. Precipitated L
d molecules were resolved by 
SDS­PAGE and blotted for newly ubiquitinated L
d by anti­HA. An anti­L
d blot was included to show the level of L
d molecules in each cell line. (D) Same as in 
C except that WT3 cells expressing 1S L
d and mK3 were used. (A–D) Molecular mass is indicated in kilodaltons. IB, immunoblot; IP, immunoprecipitation.
 
Figure 4.  Ub conjugates on WT L
d molecules 
induced by mK3 are sensitive to mild alkaline 
treatment. (A) WT3 cells expressing mK3 and 
WT L
d or one of the mutants L
d 1K, L
d 1S, or L
d 
CKST were permeabilized, cytosol depleted, 
and incubated with E1, Ube2j2, and HA­Ub. 
After treatment with PBS or 0.1 M NaOH for   
1 h at 37°C, L
d HC precipitates from these cells 
were  neutralized  and  resolved  by  reducing 
SDS­PAGE and then blotted with anti­HA and 
anti­L
d. A background Ig heavy chain band can 
be seen in the blot. Data are representative 
of  two  independent  experiments. (B)  L
d  HCs 
were precipitated from cells used in A without 
permeabilization. After NaOH treatment, SDS­
PAGE and immunoblotting were conducted as 
in A, except using anti­Ub to visualize ubiqui­
tinated L
d HC. The ­actin and mK3 blots on the 
right were included to show a similar amount 
of input lysate and mK3 in each cell line. Data 
are representative of three independent experi­
ments. (A and B) Molecular mass is indicated 
in kilodaltons. IP, immunoprecipitation.JCB • VOLUME 187 • NUMBER 5 • 2009   662
Figure 5.  Ube2j2–mK3 favors ubiquitination of S residues over K residues on the tail of HC substrates. (A) WT3 cells expressing mK3 and L
d 1K (329K) 
or L
d 1S (329S) were permeabilized, cytosol depleted, and incubated with E1, Ube2j2, and HA­Ub in the presence or absence of 2 µM Ub­Al, a DUB 
inhibitor. After treatment with PBS or NaOH for 45 min, L
d HC precipitates from these cells were neutralized and resolved by reducing SDS­PAGE and 
then blotted with anti­HA and anti­L
d. Background Ig heavy chain bands can be seen in the blot. Quantification of Ub2­L
d bands from PBS treatment in 
the gel is shown in the graph. Samples from cytosolic proteins and pellets of each line were blotted to verify an equal amount of mK3 expression (right).   
(B) WT3 cells expressing mK3 and WT L
d or L
d 1K were permeabilized and incubated with E1, Ube2j2, and HA­Ub in the presence or absence of Ub­Al. 
All other steps were performed as in A. (C) Same as in A, except permeabilized cells expressing mK3 and WT L
d were incubated with either Ube2d1 
or Ube2j2 in the presence of Ub­Al. Data shown are representative of two independent experiments. (A–C) Molecular mass is indicated in kilodaltons. 
IP, immunoprecipitation.663 Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
Sequences in addition to the RING-CH  
domain of the ligase are critical 
for ubiquitination of substrates via 
nonisopeptide bonds
Unlike mK3, kK3 and kK5 ligases ubiquitinate HCs in a post-ER 
compartment, resulting in their rapid endocytosis and lyso-
somal degradation (Lehner et al., 2005). The cognate E2s of 
kK3 have been identified as Ubc5b/c (Ube2d2/3) and Ubc13 
(Ube2n), which catalyze a K63-linked poly-Ub chain on the tail 
of the HCs (Duncan et al., 2006). Moreover, both kK3 and kK5 
can facilitate Ub conjugation of C and K residues (Cadwell and 
Coscoy, 2005, 2008) and not S/T residues like mK3. Whether   
the same or different E2s facilitate a C ubiquitination versus 
a K ubiquitination by kK3 and kK5 has not yet been reported. 
Nevertheless, the fact that mK3 and kK3/kK5 have similar 
overall structures with highly homologous RING-CH domains 
make them valuable probes for understanding the determinants and 
consequences of specific E2–E3 interactions with each other 
and with substrates. To determine the importance of the RING-CH 
domain  in  E2  selection  and  the  potential  to  ubiquitinate   
hydroxylated residues, the RING domains of kK3 and kK5 were 
each swapped into mK3. Each of these RING swap constructs 
was introduced into cells expressing WT L
d or L
d mutants with 
only C, K, S, or T residues available in the tail. As expected, 
both kK3 and kK5 RINGs in the context of mK3-mediated ro-
bust ubiquitination of K, S, or T but not C in tails of the HC in 
these cells (unpublished data). Their lack of ability to efficiently 
conjugate C residues is not caused by the position of the C resi-
due because other positions were tested, including sites proxi-
mal to the C terminus of the tail, as favored by intact kK3 ligase 
(Herr et al., 2009). Thus, in the context of mK3, the RING do-
mains of kK3 or kK5 no longer supported ubiquitination of   
C residues like their intact ligases but facilitated S or T ubiquitina-
tion like intact mK3. Furthermore, in our permeabilized cell 
system, Ube2j2 and not Ube2n interacted with kK3 or kK5 
RING swaps to greatly enhance the ubiquitination on an S resi-
due of the tail of HC (Fig. 6 A, left and right, respectively). 
Accordingly, the Ub chains formed on the tail of L
d 1S molecules 
in kK3 or kK5 swap–expressing cells were Ub K48 and not K63 
dependent (Fig. 6 B), which is the same as what was observed 
with WT mK3 (Fig. S4). Collectively, these data demonstrate 
that sequences outside the RING domain of mK3 ligase are 
critical determinants for which E2 is recruited, which non-K 
residues can be ubiquitinated, and which linkage is used for 
poly-Ub chain assembly.
Discussion
Nonisopeptide  bond–linked  substrate  ubiquitination  was  ini-
tially  shown  with  homologous  RING-CH–type  viral  ligases 
from KSHV and -HV68. More specifically, the kK3 and kK5 
ligases of KSHV were shown to ubiquitinate C residues on HC, 
thereby inducing their rapid endocytosis and degradation in the 
lysosome (Cadwell and Coscoy, 2005, 2008). In addition, we   
demonstrated that ubiquitination of HCs by -HV68 ligase 
mK3 can occur via an ester bond to hydroxylated amino acids 
(S or T), resulting in ERAD of the HCs (Wang et al., 2007). 
These findings have raised considerable interest in understanding 
the molecular basis and physiological importance of this non-
conventional ubiquitination. In this study, we show that Ube2j2 
can promote the ubiquitination on HC mutants having only 1S 
or only 1K on the tail. Consistent with their ester linkage, Ub 
conjugates on the 1S mutant were substantially more labile to 
the mild alkaline treatment than Ub conjugates on 1K mutants. 
Furthermore, regardless of whether S or K residues of substrate 
HCs were ubiquitinated, the poly-Ub chain was assembled with 
K48 linkages (Fig. S4). Thus, these findings demonstrate that 
a specialized Ub-conjugating enzyme is not required; instead, 
the same E2 cooperates with mK3 to promote either ester bonds 
or isopeptide bonds between Ub and substrate. We previously 
found that there are no sequence constraints around either K or 
S/T ubiquitination sites on HC substrates but that a certain prox-
imity from the ER membrane is required (Wang et al., 2007; 
Herr et al., 2009). These combined findings suggest a model 
whereby the correct position or orientation of Ube2j2 relative 
to the substrate is imposed by mK3 and that this is a common 
requirement for both K and S/T ubiquitination. Surprisingly we 
find that Ub conjugates on the WT L
d molecules mediated by 
mK3–Ube2j2 are mainly linked via hydroxylated residues even 
though WT L
d contains multiple Ks in the tail. This S/T ubiq-
uitination preference by Ube2j2 is observed when C protease 
DUB activity is inhibited and thus cannot be explained by DUB 
more efficiently cleaving K-linked Ub conjugates. Given the 
fact that there has been increasing evidence showing that non-
conventional ubiquitination may occur on multiple substrates 
in different cellular pathways, it is very likely an underappreci-
ated mechanism. The flexibility of the selection of conjugation 
residues may lead to more efficient Ub modification and would 
benefit protein quality control for proteins having no K residues 
accessible for ubiquitination. Furthermore, because S or T resi-
dues are also sites of phosphorylation, it is attractive to specu-
late that there is cross talk between two major posttranslational 
modifications, ubiquitination and phosphorylation.
The mechanistic basis for the preferential S/T ubiqui-
tination of substrates by Ube2j2–mK3 remains undefined. 
However, the transmembrane domain (TMD) of Ubc6p has 
been shown to play a dominant role in its ER localization and 
is required for its in vivo function (Chen et al., 1993; Yang   
et al., 1997). Interestingly, in this study, we show that soluble 
Ube2j2 in which the TMD is deleted is capable of restoring 
the Ub conjugation of S residues on HC substrates after inhi-
bition of native Ube2j2 by shRNA. Thus, the TMD of Ube2j2 
is not required for non-K ubiquitination and is not likely to 
be involved in its interaction with mK3. However, the TMD 
may facilitate the localization of Ube2j2 in the ER, which   
is  compensated  by  the  overexpression  of  soluble  Ube2j2   
in a permeabilized cell system. It should be noted that we 
were not able to coprecipitate Ube2j2 with mK3, suggesting 
that  their  interaction  may  be  transient.  Such  a  transient   
interaction would contrast with the strong binding of the E3 
ligase gp78 to Ube2g2, as mediated by its G2BR domain 
(Chen et al., 2006). Nevertheless, mK3 is the first E3 ligase 
in  mammals  found  to  interact  with  Ube2j2  and  promote   
the ubiquitination and ERAD of its substrate. This defined JCB • VOLUME 187 • NUMBER 5 • 2009   664
Interestingly, in our permeabilized cell assays, a second 
E2, Ube2d1, supported mK3-induced ubiquitination of HC. 
However, in contrast to Ube2j2, Ube2d1 facilitated ubiquitination 
E2–E3–substrate interaction will be a foundation for future 
functional characterization of Ube2j2 as well as dissection of 
the mechanism of S/T ubiquitination.
Figure 6.  The kK3 and kK5 RINGs in the context of mK3 interact with Ube2j2 to promote the formation of K48-linked Ub chain on S residues of the HCs. 
(A) kK3 or kK5 RING­mK3 chimeric molecules were expressed in WT3–L
d 1S cells. After permeabilization and depletion of cytosolic proteins, aliquots of 
these cells were incubated with no enzyme, E1 only, or E1 plus one of the two E2s in the presence of ATP and HA­Ub. L
d HCs were immunoprecipitated and 
blotted as indicated. (B) Aliquots of the cells used in A were incubated with ATP, E1, and WT or mutant HA­Ub in an ubiquitination assay of permeabilized 
cells as described in A. Immunoprecipitation (IP) of L
d and blotting by anti­HA (top) or anti­Ub (middle) antibodies shows newly formed Ub­L
d HCs and total 
Ub­L
d HCs, respectively. The conjugates formed by HA­Ub are in red. (A and B) Molecular mass is indicated in kilodaltons. IB, immunoblot.665 Nonconventional ubiquitination by Ube2j2–mK3 • Wang et al.
2006; Mueller et al., 2008). Furthermore, it was recently found 
that Ube2g2 alone can interact with gp78 in vitro to transfer a 
preassembled K48-linked Ub chain to a substrate (Li et al., 
2007). Our study shows that both Ube2d1 and Ube2j2 are capa-
ble of interacting with mK3 to facilitate K48-linked poly-Ub 
conjugation to the HCs (Fig. S4 B). However, in vivo, only 
Ube2j2 is primarily required for mK3 function because inhibi-
tion of Ube2j2 alone impaired HC ubiquitination and degrada-
tion, whereas inhibition of Ube2d1 in vivo had no such effect. 
Given the fact that Ube2d family members have never been 
found in association with an ER membrane E3, it is possible 
that the subcellular localization of Ube2d1 prevents its partici-
pation in ERAD. Alternatively, because S residues are the pri-
mary sites of ubiquitination on WT L
d tails, only depletion of 
Ube2j2 and not Ube2d1 would be expected to impair mK3-
mediated ubiquitination and ERAD of HC substrates. In support 
of this model, inhibition of Ube2j2 strikingly impairs HC ubiq-
uitination, including Ub1-L
d forms on the WT HC and Ub con-
jugation on the 1S HC mutant. All of these Ub conjugates were 
found to be sensitive to mild alkaline treatment, which is con-
sistent with ester linkage. Thus, our data demonstrate that 
Ube2j2 is primarily responsible for initial ubiquitination and 
Ub chain assembly on HC substrates.
Our findings also have implications on the mechanism 
of mK3-induced Ub chain assembly. Interestingly, although 
Ube2j2–mK3 primarily ubiquitinates hydroxylated amino acids 
on L
d substrates, it promotes a K48-linked poly-Ub chain. This 
suggests that the determinants for attachment of the initial Ub 
and assembly of the Ub chain are different. Curiously, in this 
and other studies of mK3 ubiquitination by us and others 
(Boname and Stevenson, 2001; Wang et al., 2007), Ub1 modifica-
tions were only weakly detected relative to predominant Ub2 
and Ub3 polychains on HC substrates. However, Ub1-L
d forms 
were clearly observed along with the overall increase in ubiqui-
tination seen after inhibition of C protease DUBs. Thus, Ub1-HC 
forms may be transient, reflecting rapid chain elongation 
which is retarded in the presence of DUBs. This observation is 
similar to a study with the yeast cullin-RING Ub ligase SCF 
(Skp1–Cul1–F box protein) and Ub-conjugating enzyme Cdc34 
(Petroski and Deshaies, 2005). SCF interacts with a single E2, 
Cdc34, to catalyze both the attachment of the first Ub and elon-
gation of a specific Ub chain on substrate. However, these two 
reactions occur with strikingly different kinetics in which the 
first step is relatively slow followed by rapid chain elongation 
(Petroski and Deshaies, 2005). Alternatively, Ub chain assem-
bly by mK3 may preferentially initiate with the addition of two 
Ub moieties. Such a strategy would be similar to that of gp78–
Ube2g2 (Li et al., 2007, 2009). It was recently shown that ER-
associated E3 ligase gp78 interacting with Ube2g2 mediated the 
attachment of preassembled K48-linked Ub chain to substrate 
by the formation of a gp78–Ube2g2 hetero-oligomer (Li et al., 
2009). Although the precise molecular strategy used by mK3–
Ube2j2 for Ub assembly is currently unknown, the predomi-
nance and specificity by which mK3–Ube2j2 interacts with HC 
substrates will allow us to further dissect this process. In sum-
mary, we identify Ube2j2 as the primary E2 required for mK3 
function. Mechanistically, our findings demonstrate that Ube2j2 
on L
d 1K molecules but not on L
d 1S molecules in the pres-
ence of mK3. In addition, Ube2d1–mK3-promoted Ub conju-
gates on the WT HCs were stable in mild alkaline conditions, 
confirming an isopeptide bond linkage. These results indicate 
that mK3-recruited Ube2d1 can only catalyze the formation of 
isopeptide bonds between Ub and substrate but not ester bonds. 
Different from Ube2j2, which has a C-terminal extension and a 
TMD, Ube2d1 is comprised exclusively of the core catalytic 
domain (Scheffner et al., 1994). Ube2d1 has been shown to 
have broad E3-interacting activity, including HECT (homolo-
gous to the E6-AP C terminus)-, RING-, and U box–type E3s, 
to promote Ub conjugation on K residues of substrates (Lorick 
et al., 2005). In addition, Grou et al. (2008) recently reported 
that all three closely related Ube2d family members, Ube2d1, 
-2, and -3, can support ubiquitination of a C residue on Pex5p, 
a peroxisomal import receptor. In yeast, this process is mediated 
by a specialized Ub-conjugating enzyme, Pex4p (Williams et al., 
2007). These findings suggest that Ube2d members have the 
potential to catalyze both K and non-K ubiquitination. How-
ever, in the Grou et al. (2008) study, Ube2d members were only 
shown to mediate the ubiquitination on C residues of Pex5p, 
and the E3 ligase has not been defined. Therefore, it is not clear 
whether these Ube2d members can catalyze both types of ubiq-
uitinations when interacting with the same E3. Furthermore, 
thiolesteration between C residues and Ub is a standard reaction 
used during charging of E1, E2, or HECT-type E3 with Ub. 
Thus, the question remains whether an E2 capable of promoting 
thiolesteration can also catalyze the addition of Ub to hydroxyl-
ated amino acids. In this study, we clearly demonstrate that 
Ube2d1 is capable of mK3-induced HC ubiquitination on   
K residues but lacks the ability to ubiquitinate S residues. The 
mechanistic implication of these findings is that not all E2s 
capable of interacting with mK3 can catalyze both K and S/T 
ubiquitination, implying that non-K ubiquitination requires a 
specific E2–E3 interaction. It should be noted that among seven 
E2s tested in our system, Ube2d1 shares more predicted E3 
interaction sites with Ube2j2 than the other E2s tested (4/5 vs. 
≤3 conserved residues). Furthermore, comparison of available 
structures of homologues of mouse Ube2d1 and Ube2j2 shows 
a similar E3 interaction surface, but they vary around their cata-
lytic C residues.
A single E3 ligase can interact with more than one E2, as 
demonstrated in several in vitro and a few in vivo studies (Chen 
et al., 1993; Christensen et al., 2007; Rodrigo-Brenni and 
Morgan, 2007; Windheim et al., 2008). This redundancy adds 
another apparent layer of regulation in Ub modification. How-
ever, precise consequences of two or more E2s cooperating with 
a particular E3 remains largely undefined. Recently proposed 
models have speculated that certain E2s can primarily catalyze 
the conjugation of the initial Ub moiety to the substrate, whereas 
other E2s assemble the poly-Ub chain with either K48 or K63 
linkages  (Christensen  et  al.,  2007;  Windheim  et  al.,  2008). 
Whether this sequentially acting E2 model also functions in 
ERAD is currently unknown. Although ERAD-implicated E3 
ligases have been shown to interact with more than one E2, it is 
unclear whether these distinct E2s combine to polyubiquitinate 
substrates (Bays et al., 2001; Kikkert et al., 2004; Arteaga et al., JCB • VOLUME 187 • NUMBER 5 • 2009   666
twice, the cells were resuspended in potassium acetate buffer (25 mM 
Hepes, pH 7.4, 115 mM KOAc, 5 mM NaOAc, 2.5 mM MgCl2, and 
0.5 mM EGTA) containing 0.02% digitonin (Wako Chemicals USA, Inc.) 
at 0.5–1.0 × 10
7/ml and incubated on ice for 20 min. Soluble cytosolic 
proteins were squeezed out by centrifugation of digitonin­treated cells at 
18,000 g and 4°C for 20 min and washed once with potassium acetate 
buffer. These soluble protein–depleted cells were then incubated for 45 min 
at 37°C with 50 nM E1 (human Ub­activating enzyme; Boston Biochem) or 
2.5 mg/ml FII from rabbit reticulocyte extract (Boston Biochem), 20 µM 
HA­Ub, and 1.25 µM candidate E2 in 25 mM Tris­HCl, pH 7.4, buffers 
containing an ATP­regenerating system (10 mM MgOAc, 300 mM phospho­
creatine,  0.6  mg/ml  creatine  phosphokinase,  and  2  mM  ATP),  1  mM 
PMSF, and 50 µM MG132. 2 µM Ub­Al (Boston Biochem) was included 
when indicated. After incubation, ubiquitinated HCs were visualized by 
immunoprecipitation of L
d molecules and then blotting for tagged Ub by 
anti­HA antibody.
Recombinant E2s and HA-Ub proteins
Recombinant  proteins  used  in  this  study,  including  mouse  Ube2g1, 
Ube2g2,  soluble  Ube2j1  (1–285  aa),  soluble  Ube2j2  (1–226  aa), 
Ube2k, HA­Ub, and its mutants, were expressed as GST fusion proteins 
in E. coli (BL21­CODONPLUS­RIL; Agilent Technologies) by pGEX4T (GE 
Healthcare).  The  GST  fusion  proteins  were  purified  with  glutathione 
beads (GE Healthcare) from the bacteria lysates according to the manu­
facturer’s instructions. The recombinant proteins were cleaved from the 
beads using thrombin (Sigma­Aldrich). The activity of purified recombi­
nant E2s was assessed using a thiolester formation assay and compared 
with  the  commercial  E2s  UbcH5a  and  His6­UbcH13–Uev1a  complex 
(Boston Biochem), which have the same amino acid sequence as mouse 
Ube2d1 and Ube2n. Purified recombinant HA­Ub proteins possessing 
two vector­derived amino acid remains (GS) at the N terminus were com­
pared with commercial HA­Ub (Boston Biochem) in a thiolester formation 
assay with functional E2. Aliquots of the aforementioned purified proteins 
were stored at 80°C in 50 mM Tris­HCl, pH 8.0, 150 mM KCl, 2 mM 
MgCl2, and 5% glycerol.
Online supplemental material
Fig. S1 shows that ubiquitination of HCs in permeabilized cells is depen­
dent on the RING domain of mK3. Fig. S2 shows that the recombinant E2s 
used in this study had similar enzymatic activity and protein level, as deter­
mined by in vitro thiolester formation and silver stain. Fig. S3 shows the in­
hibition by shRNA of targeted E2s, as determined by quantitative RT­PCR. 
Fig. S4 shows that mK3­facilitated poly­Ub chains on either S or K residues 
of HCs are dependent on K48 of Ub. Table S1 shows the shRNA sequences 
used in this study. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200908036/DC1.
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Materials and methods
Cell lines
Murine cell line B6/WT3 (WT3; H-2
b) was described previously (Wang 
et al., 2004). The Vpack vector system (Agilent Technologies) and vectors 
pHR’8.2∆R and pCMV­VSV­G (provided by S. Stewart, Washington Uni­
versity School of Medicine, St. Louis, MO) were used to produce retrovirus 
and lentivirus in 293T cells (DuBridge et al., 1987). Cells transduced by 
pMSCV.IRES.neo (pMIN)­, pSRPU6­, or pLKO.1­based constructs were se­
lected by corresponding antibiotics, whereas GFP
+ cells from pMSCV.IRES.
GFP (pMIG)­transduced lines were enriched by cell sorting. Where indi­
cated, cells were cultured for 24 h with 125 U/ml of mouse IFN­ (Invitro­
gen)  and  for  2–3  h  with  50–60  µM  of  proteasome  inhibitor  MG132 
(Boston Biochem) before harvesting with trypsin­EDTA.
DNA constructs
Two retroviral expression vectors, pMIG and pMIN (Wang et al., 2004), 
were used to express mK3 and L
d constructs, respectively. The retroviral 
shRNA expression vector pSRPU6 was modified from pSUPER.retro.puro 
(Oligoengine) by replacing the H1 promoter with the human U6 promoter. 
The lentiviral shRNA expression vector pLKO.1 was provided by S. Stewart. 
mK3 sequence from a ­HV68 subclone (Virgin et al., 1997), kK5 se­
quence from a KSHV subclone (provided by H.W. Virgin IV, Washington 
University School of Medicine), and kK3 sequence from BCBL­1 (provided 
by J.U. Jung, Harvard Medical School, Southborough, MA) were obtained 
by PCR amplification. The kK5 or kK3 RING­mK3 chimeric constructs were 
made by replacing the RING­CH of mK3 (1–51 aa) in pMIG.mK3 with the 
RING­CH of kK5 (1–59 aa) or kK3 (1–53 aa) using overlap PCR. The L
d 
mutants were generated by site­directed mutagenesis (Agilent Technolo­
gies) as described previously (Wang et al., 2007). The sequences for all of 
the constructs were confirmed by DNA sequencing. The shRNA sequences 
and sources used in this study are listed in Table S1.
Antibodies
Antibodies to mK3 and L
d (30­5­7 and 64­3­7) were previously described 
(Smith et al., 1992; Lybarger et al., 2003). Antibodies to Ub (P4D1), ­actin 
(AC­74), Ube2k, Ube2n, and HA.11 (clone 16B12) were purchased from 
Santa Cruz Biotechnology, Inc., Sigma­Aldrich, Cell Signaling Technology, 
AnaSpec, and Covance, respectively.
Immunoprecipitation and immunoblots
Cells were lysed in PBS buffer containing 1% NP­40, 20 mM iodoacetamide 
(Sigma­Aldrich), and protease inhibitors (complete mini [Roche] and 0.4 mM 
PMSF [Sigma­Aldrich]). Postnuclear lysates were incubated with protein A–
Sepharose 4B beads (Sigma­Aldrich) and antibodies. After washing beads 
four times with PBS/iodoacetamide buffer containing 0.15% NP­40, immuno­
precipitates were eluted from protein A by boiling 3–5 min in lithium dodecyl 
sulfate sample buffer (Invitrogen). For Endo H treatment, immunoprecipitates 
were eluted in 10 mM Tris­HCl, pH 6.8, with 0.5% SDS; the eluates then were 
mixed with an equal volume of 100 mM Na acetate, pH 5.4, and incubated 
with 1 µU Endo H at 37°C for 2 h. For alkaline treatment, immunoprecipitates 
were boiled in 0.5% SDS for 3 min followed by incubation in 0.1 M NaOH 
for 1 h at 37°C. Immunoblotting was performed after SDS­PAGE separation of 
precipitated proteins or postnuclear cell lysates on Immobilon­P transfer mem­
branes (Millipore). Specific proteins were visualized by chemiluminescence 
using the ECL system (Thermo Fisher Scientific).
Metabolic labeling and pulse–chase
After 30 min of preincubation in Cys­ and Met­free medium (MEM­Earle’s 
with 5% dialyzed FCS), cells were pulse labeled with Express [
35S]Cys/
Met labeling mix (PerkinElmer) at 200 µCi/ml for 15 min. Chase was initi­
ated by the addition of an excess of unlabeled Cys/Met (5 mM each). 
Immunoprecipitation was performed as described in the previous section. 
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